Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

PET-based dosimetry of [68Ga]Ga-NODAGA-exendin-4 in humans, a tracer for beta cell imaging.

Boss M, Buitinga M, Jansen TJ, Brom M, Visser EP, Gotthardt M.

J Nucl Med. 2019 Sep 13. pii: jnumed.119.228627. doi: 10.2967/jnumed.119.228627. [Epub ahead of print]

PMID:
31519801
2.

Exendin-4 analogs in insulinoma theranostics.

Jansen TJP, van Lith SAM, Boss M, Brom M, Joosten L, Béhé M, Buitinga M, Gotthardt M.

J Labelled Comp Radiopharm. 2019 Aug;62(10):656-672. doi: 10.1002/jlcr.3750.

PMID:
31070270
3.

PET imaging during hypoglycaemia to study adipose tissue metabolism.

Boss M, Rooijackers HMM, Buitinga M, Janssen MJR, Arens AIJ, de Geus-Oei LF, Salm LP, de Galan BE, Gotthardt M.

Eur J Clin Invest. 2019 Jul;49(7):e13120. doi: 10.1111/eci.13120. Epub 2019 Apr 29.

4.

Radiofrequency transmit calibration: A multi-center evaluation of vendor-provided radiofrequency transmit mapping methods.

Bliesener Y, Zhong X, Guo Y, Boss M, Bosca R, Laue H, Chung C, Sung K, Nayak KS.

Med Phys. 2019 Jun;46(6):2629-2637. doi: 10.1002/mp.13518. Epub 2019 Apr 15.

PMID:
30924940
5.

E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms.

Jolly MK, Ware KE, Xu S, Gilja S, Shetler S, Yang Y, Wang X, Austin RG, Runyambo D, Hish AJ, Bartholf DeWitt S, George JT, Kreulen RT, Boss MK, Lazarides AL, Kerr DL, Gerber DG, Sivaraj D, Armstrong AJ, Dewhirst MW, Eward WC, Levine H, Somarelli JA.

Mol Cancer Res. 2019 Jun;17(6):1391-1402. doi: 10.1158/1541-7786.MCR-18-0763. Epub 2019 Mar 12.

PMID:
30862685
6.

Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs.

Keenan KE, Biller JR, Delfino JG, Boss MA, Does MD, Evelhoch JL, Griswold MA, Gunter JL, Hinks RS, Hoffman SW, Kim G, Lattanzi R, Li X, Marinelli L, Metzger GJ, Mukherjee P, Nordstrom RJ, Peskin AP, Perez E, Russek SE, Sahiner B, Serkova N, Shukla-Dave A, Steckner M, Stupic KF, Wilmes LJ, Wu HH, Zhang H, Jackson EF, Sullivan DC.

J Magn Reson Imaging. 2019 Jun;49(7):e26-e39. doi: 10.1002/jmri.26598. Epub 2019 Jan 24.

PMID:
30680836
7.

Succinylated Gelatin Improves the Theranostic Potential of Radiolabeled Exendin-4 in Insulinoma Patients.

Buitinga M, Jansen T, van der Kroon I, Woliner-van der Weg W, Boss M, Janssen M, Aarntzen E, Béhé M, Wild D, Visser E, Brom M, Gotthardt M.

J Nucl Med. 2019 Jun;60(6):812-816. doi: 10.2967/jnumed.118.219980. Epub 2018 Nov 30.

PMID:
30504139
8.

Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials.

Shukla-Dave A, Obuchowski NA, Chenevert TL, Jambawalikar S, Schwartz LH, Malyarenko D, Huang W, Noworolski SM, Young RJ, Shiroishi MS, Kim H, Coolens C, Laue H, Chung C, Rosen M, Boss M, Jackson EF.

J Magn Reson Imaging. 2019 Jun;49(7):e101-e121. doi: 10.1002/jmri.26518. Epub 2018 Nov 19. Review.

PMID:
30451345
9.

Structural and Functional Analyses of the Shedding Protease ADAM17 in HoxB8-Immortalized Macrophages and Dendritic-like Cells.

Cabron AS, El Azzouzi K, Boss M, Arnold P, Schwarz J, Rosas M, Dobert JP, Pavlenko E, Schumacher N, Renné T, Taylor PR, Linder S, Rose-John S, Zunke F.

J Immunol. 2018 Nov 15;201(10):3106-3118. doi: 10.4049/jimmunol.1701556. Epub 2018 Oct 24.

10.

Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closer.

Gotthardt M, Eizirik DL, Aanstoot HJ, Korsgren O, Mul D, Martin F, Boss M, Jansen TJP, van Lith SAM, Buitinga M, Eriksson O, Cnop M, Brom M.

Diabetologia. 2018 Dec;61(12):2516-2519. doi: 10.1007/s00125-018-4745-5. Epub 2018 Oct 3.

11.

Author Correction: Large T1 contrast enhancement using superparamagnetic nanoparticles in ultra-low field MRI.

Yin X, Russek SE, Zabow G, Sun F, Mohapatra J, Keenan KE, Boss MA, Zeng H, Liu JP, Viert A, Liou SH, Moreland J.

Sci Rep. 2018 Aug 31;8(1):13272. doi: 10.1038/s41598-018-31702-0.

12.

Assessment of quantitative magnetic resonance imaging metrics in the brain through the use of a novel phantom.

Wilde EA, Provenzale JM, Taylor BA, Boss M, Zuccolotto A, Hachey R, Pathak S, Tate DF, Abildskov TJ, Schneider W.

Brain Inj. 2018;32(10):1266-1276. doi: 10.1080/02699052.2018.1494855.

PMID:
30169993
13.

Large T1 contrast enhancement using superparamagnetic nanoparticles in ultra-low field MRI.

Yin X, Russek SE, Zabow G, Sun F, Mohapatra J, Keenan KE, Boss MA, Zeng H, Liu JP, Viert A, Liou SH, Moreland J.

Sci Rep. 2018 Aug 8;8(1):11863. doi: 10.1038/s41598-018-30264-5. Erratum in: Sci Rep. 2018 Aug 31;8(1):13272.

14.

Analysis of variability of fractional anisotropy values at 3T using a novel diffusion tensor imaging phantom.

Provenzale JM, Taylor BA, Wilde EA, Boss M, Schneider W.

Neuroradiol J. 2018 Dec;31(6):581-586. doi: 10.1177/1971400918789383. Epub 2018 Jul 24.

PMID:
30037296
15.

Normal Human Lactation: closing the gap.

Boss M, Gardner H, Hartmann P.

F1000Res. 2018 Jun 20;7. pii: F1000 Faculty Rev-801. doi: 10.12688/f1000research.14452.1. eCollection 2018. Review.

16.

Stereotactic radiation therapy for the treatment of functional pituitary adenomas associated with feline acromegaly.

Wormhoudt TL, Boss MK, Lunn K, Griffin L, Leary D, Dowers K, Rao S, LaRue SM.

J Vet Intern Med. 2018 Jul;32(4):1383-1391. doi: 10.1111/jvim.15212. Epub 2018 May 21.

17.

Toward uniform implementation of parametric map Digital Imaging and Communication in Medicine standard in multisite quantitative diffusion imaging studies.

Malyarenko D, Fedorov A, Bell L, Prah M, Hectors S, Arlinghaus L, Muzi M, Solaiyappan M, Jacobs M, Fung M, Shukla-Dave A, McManus K, Boss M, Taouli B, Yankeelov TE, Quarles CC, Schmainda K, Chenevert TL, Newitt DC.

J Med Imaging (Bellingham). 2018 Jan;5(1):011006. doi: 10.1117/1.JMI.5.1.011006. Epub 2017 Oct 30.

18.

Quantitative magnetic resonance imaging phantoms: A review and the need for a system phantom.

Keenan KE, Ainslie M, Barker AJ, Boss MA, Cecil KM, Charles C, Chenevert TL, Clarke L, Evelhoch JL, Finn P, Gembris D, Gunter JL, Hill DLG, Jack CR Jr, Jackson EF, Liu G, Russek SE, Sharma SD, Steckner M, Stupic KF, Trzasko JD, Yuan C, Zheng J.

Magn Reson Med. 2018 Jan;79(1):48-61. doi: 10.1002/mrm.26982. Epub 2017 Oct 30. Review.

19.

Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network.

Newitt DC, Malyarenko D, Chenevert TL, Quarles CC, Bell L, Fedorov A, Fennessy F, Jacobs MA, Solaiyappan M, Hectors S, Taouli B, Muzi M, Kinahan PE, Schmainda KM, Prah MA, Taber EN, Kroenke C, Huang W, Arlinghaus LR, Yankeelov TE, Cao Y, Aryal M, Yen YF, Kalpathy-Cramer J, Shukla-Dave A, Fung M, Liang J, Boss M, Hylton N.

J Med Imaging (Bellingham). 2018 Jan;5(1):011003. doi: 10.1117/1.JMI.5.1.011003. Epub 2017 Oct 10.

20.

Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives.

deSouza NM, Winfield JM, Waterton JC, Weller A, Papoutsaki MV, Doran SJ, Collins DJ, Fournier L, Sullivan D, Chenevert T, Jackson A, Boss M, Trattnig S, Liu Y.

Eur Radiol. 2018 Mar;28(3):1118-1131. doi: 10.1007/s00330-017-4972-z. Epub 2017 Sep 27. Review.

21.

Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study.

Bane O, Hectors SJ, Wagner M, Arlinghaus LL, Aryal MP, Cao Y, Chenevert TL, Fennessy F, Huang W, Hylton NM, Kalpathy-Cramer J, Keenan KE, Malyarenko DI, Mulkern RV, Newitt DC, Russek SE, Stupic KF, Tudorica A, Wilmes LJ, Yankeelov TE, Yen YF, Boss MA, Taouli B.

Magn Reson Med. 2018 May;79(5):2564-2575. doi: 10.1002/mrm.26903. Epub 2017 Sep 14.

22.

Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.

Boss MK, Dewhirst MW, Sampaio RS, Bennett A, Tovmasyan A, Berman KG, Beaven AW, Rizzieri DA, Batinic-Haberle I, Hauck ML, Spasojevic I.

Cancer Chemother Pharmacol. 2017 Aug;80(2):421-431. doi: 10.1007/s00280-017-3372-z. Epub 2017 Jul 6.

23.

Translational research in radiation-induced DNA damage signaling and repair.

Nickoloff JA, Boss MK, Allen CP, LaRue SM.

Transl Cancer Res. 2017 Jul;6(Suppl 5):S875-S891. doi: 10.21037/tcr.2017.06.02.

24.

Comparison Between 3-Scan Trace and Diagonal Body Diffusion-Weighted Imaging Acquisitions: A Phantom and Volunteer Study.

Hectors SJ, Wagner M, Corcuera-Solano I, Kang M, Stemmer A, Boss MA, Taouli B.

Tomography. 2016 Dec;2(4):411-420. doi: 10.18383/j.tom.2016.00229.

25.

Toward Precision and Reproducibility of Diffusion Tensor Imaging: A Multicenter Diffusion Phantom and Traveling Volunteer Study.

Palacios EM, Martin AJ, Boss MA, Ezekiel F, Chang YS, Yuh EL, Vassar MJ, Schnyer DM, MacDonald CL, Crawford KL, Irimia A, Toga AW, Mukherjee P; TRACK-TBI Investigators.

AJNR Am J Neuroradiol. 2017 Mar;38(3):537-545. doi: 10.3174/ajnr.A5025. Epub 2016 Dec 22.

26.

AMPK-independent inhibition of human macrophage ER stress response by AICAR.

Boß M, Newbatt Y, Gupta S, Collins I, Brüne B, Namgaladze D.

Sci Rep. 2016 Aug 26;6:32111. doi: 10.1038/srep32111.

27.

Development of a temperature-controlled phantom for magnetic resonance quality assurance of diffusion, dynamic, and relaxometry measurements.

Jerome NP, Papoutsaki MV, Orton MR, Parkes HG, Winfield JM, Boss MA, Leach MO, deSouza NM, Collins DJ.

Med Phys. 2016 Jun;43(6):2998-3007. doi: 10.1118/1.4948997.

PMID:
27277048
28.

Design of a breast phantom for quantitative MRI.

Keenan KE, Wilmes LJ, Aliu SO, Newitt DC, Jones EF, Boss MA, Stupic KF, Russek SE, Hylton NM.

J Magn Reson Imaging. 2016 Sep;44(3):610-9. doi: 10.1002/jmri.25214. Epub 2016 Mar 7.

29.

N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators.

Blöcher R, Lamers C, Wittmann SK, Merk D, Hartmann M, Weizel L, Diehl O, Brüggerhoff A, Boß M, Kaiser A, Schader T, Göbel T, Grundmann M, Angioni C, Heering J, Geisslinger G, Wurglics M, Kostenis E, Brüne B, Steinhilber D, Schubert-Zsilavecz M, Kahnt AS, Proschak E.

J Med Chem. 2016 Jan 14;59(1):61-81. doi: 10.1021/acs.jmedchem.5b01239. Epub 2015 Dec 25.

PMID:
26595749
30.

Hypoxia Potentiates Palmitate-induced Pro-inflammatory Activation of Primary Human Macrophages.

Snodgrass RG, Boß M, Zezina E, Weigert A, Dehne N, Fleming I, Brüne B, Namgaladze D.

J Biol Chem. 2016 Jan 1;291(1):413-24. doi: 10.1074/jbc.M115.686709. Epub 2015 Nov 17.

31.

Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model.

Ashcraft KA, Boss MK, Tovmasyan A, Roy Choudhury K, Fontanella AN, Young KH, Palmer GM, Birer SR, Landon CD, Park W, Das SK, Weitner T, Sheng H, Warner DS, Brizel DM, Spasojevic I, Batinic-Haberle I, Dewhirst MW.

Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):892-900. doi: 10.1016/j.ijrobp.2015.07.2283. Epub 2015 Jul 29.

32.

Anticancer therapeutic potential of Mn porphyrin/ascorbate system.

Tovmasyan A, Sampaio RS, Boss MK, Bueno-Janice JC, Bader BH, Thomas M, Reboucas JS, Orr M, Chandler JD, Go YM, Jones DP, Venkatraman TN, Haberle S, Kyui N, Lascola CD, Dewhirst MW, Spasojevic I, Benov L, Batinic-Haberle I.

Free Radic Biol Med. 2015 Dec;89:1231-47. doi: 10.1016/j.freeradbiomed.2015.10.416. Epub 2015 Oct 20.

33.

A tribute to Philip Marcus and the development of the clonogenic assay.

Boss MK, Dewhirst M.

Radiat Res. 2015 May;183(5):497-500.

PMID:
26000758
34.

Dynamic treatment effect (DTE) curves reveal the mode of action for standard and experimental cancer therapies.

Choudhury KR, Keir ST, Ashcraft KA, Boss MK, Dewhirst MW.

Oncotarget. 2015 Jun 10;6(16):14656-68.

35.

FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.

Boss M, Kemmerer M, Brüne B, Namgaladze D.

Atherosclerosis. 2015 Jun;240(2):424-30. doi: 10.1016/j.atherosclerosis.2015.03.042. Epub 2015 Apr 3.

PMID:
25897794
36.

Activation of Melatonin Signaling Promotes β-Cell Survival and Function.

Costes S, Boss M, Thomas AP, Matveyenko AV.

Mol Endocrinol. 2015 May;29(5):682-92. doi: 10.1210/me.2014-1293. Epub 2015 Feb 19.

37.

Carcinosarcomas: tumors in transition?

Somarelli JA, Boss MK, Epstein JI, Armstrong AJ, Garcia-Blanco MA.

Histol Histopathol. 2015 Jun;30(6):673-87. doi: 10.14670/HH-30.673. Epub 2015 Jan 12. Review.

PMID:
25587806
38.

Effects of high-dose microbeam irradiation on tumor microvascular function and angiogenesis.

Fontanella AN, Boss MK, Hadsell M, Zhang J, Schroeder T, Berman KG, Dewhirst MW, Chang S, Palmer GM.

Radiat Res. 2015 Feb;183(2):147-58. doi: 10.1667/RR13712.1. Epub 2015 Jan 9.

39.

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer.

Zagar TM, Vujaskovic Z, Formenti S, Rugo H, Muggia F, O'Connor B, Myerson R, Stauffer P, Hsu IC, Diederich C, Straube W, Boss MK, Boico A, Craciunescu O, Maccarini P, Needham D, Borys N, Blackwell KL, Dewhirst MW.

Int J Hyperthermia. 2014 Aug;30(5):285-94. doi: 10.3109/02656736.2014.936049.

40.

Linking the history of radiation biology to the hallmarks of cancer.

Boss MK, Bristow R, Dewhirst MW.

Radiat Res. 2014 Jun;181(6):561-77. doi: 10.1667/RR13675.1. Epub 2014 May 8. Review.

41.

High salivary Staphylococcus aureus carriage rate among healthy paedodontic patients.

Petti S, Boss M, Messano GA, Protano C, Polimeni A.

New Microbiol. 2014 Jan;37(1):91-6. Epub 2014 Jan 15.

42.

Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor α ectodomain shedding.

Schwarz J, Schmidt S, Will O, Koudelka T, Köhler K, Boss M, Rabe B, Tholey A, Scheller J, Schmidt-Arras D, Schwake M, Rose-John S, Chalaris A.

J Biol Chem. 2014 Jan 31;289(5):3080-93. doi: 10.1074/jbc.M113.536847. Epub 2013 Dec 13.

43.

Imaging tumor hypoxia to advance radiation oncology.

Lee CT, Boss MK, Dewhirst MW.

Antioxid Redox Signal. 2014 Jul 10;21(2):313-37. doi: 10.1089/ars.2013.5759. Epub 2014 Mar 24. Review.

44.

Prototype phantoms for characterization of ultralow field magnetic resonance imaging.

Boss MA, Mates JA, Busch SE, SanGiorgio P, Russek SE, Buckenmaier K, Irwin KD, Cho HM, Hilton GC, Clarke J.

Magn Reson Med. 2014 Dec;72(6):1793-800. doi: 10.1002/mrm.25060. Epub 2013 Nov 26.

PMID:
24281979
45.

Magnetic resonance properties of Gd(III)-bound lipid-coated microbubbles and their cavitation fragments.

Feshitan JA, Boss MA, Borden MA.

Langmuir. 2012 Oct 30;28(43):15336-43. doi: 10.1021/la303283y. Epub 2012 Oct 17.

PMID:
23045962
46.

Single bead detection with an NMR microcapillary probe.

Nakashima Y, Boss M, Russek SE, Moreland J.

J Magn Reson. 2012 Nov;224:71-7. doi: 10.1016/j.jmr.2012.09.001. Epub 2012 Sep 15.

PMID:
23041798
47.

The great masquerader: atypical neuroleptic malignant syndrome after cardiac surgery.

Boss MJ, Díaz-Gómez JL, Koch C.

J Cardiothorac Vasc Anesth. 2014 Feb;28(1):121-123. doi: 10.1053/j.jvca.2012.06.033. Epub 2012 Aug 31. No abstract available.

PMID:
22939971
48.

The role of diffusion in ferritin-induced relaxation enhancement of protons.

Boss MA, Chris Hammel P.

J Magn Reson. 2012 Apr;217:36-40. doi: 10.1016/j.jmr.2012.02.005. Epub 2012 Feb 22.

PMID:
22410189
49.

DCE-MRI: a review and applications in veterinary oncology.

Boss MK, Muradyan N, Thrall DE.

Vet Comp Oncol. 2013 Jun;11(2):87-100. doi: 10.1111/j.1476-5829.2011.00305.x. Epub 2011 Dec 8. Review.

50.

Efficient dispensing of medications by a traveling health care team.

Ragland D, Campbell D, Boss M, Carey L.

Am J Health Syst Pharm. 2010 Dec 1;67(23):1992, 1994, 1996. doi: 10.2146/ajhp100136. No abstract available.

PMID:
21098369

Supplemental Content

Support Center